Development of bioassay for pathogenecity testing of Ureaplasma urealyticum as part of host-pathogen communication

  • Purnomo Soeharso
Keywords: Ureaplasma detection, Ureaplasma pathogenicity, IceC reporter gene, IgA1 protease, M. genitalium putative gene
Abstract viewed: 843 times
PDF downloaded: 308 times

Abstract

Bioassay of Ureaplasma urealyticum is necessary for detection as well as determination of pathogenic factors in order to understand the pathogenesis of diseases associate with ureaplasma infection. Cultivation and verification of ureaplasma is the first step of this study in the purpose of discovering sensitive method for ureaplasma detection. Cultivation of ureaplasma either in liquid or in solid media are able to detect the existence of ureaplasma in samples analyzed. However, application of PCR using specific primers to be compatible with urease gene (ure) would confirm the presence of ureaplasma. The pathogenicity of ureaplasma is potentially monitored using reporter gene as a marker for gene expression. IceC was chosen as reporter gene for ureaplasma pathogenic determination as the gene has great sensitivity, easily detectable and quantitated in simple method of ice nucleation assay. Transposon 916 (Tn916) was selected as a vector for iceC gene to transform ureaplasma. The application of recombinant Tn916-iceC which is considered as pUI, allow detection of ureaplasma activities when transform ureaplasma is tested by ice nucleation assay. It was expected that ureaplasma transformation is the manifestation of mutagenesis which interfere genes responsible for bacterial pathogenicity, in order pathogenesis of bacterial infection to be analyzed accurately. IgA1 protease is considered to be an important factor for ureaplasma pathogenicity as the enzyme is required for successful colonization. Identification of iga gene and  determination of IgA1 protease activity are important for understanding the pathogenesis of ureaplasma infection. Putative iga gene of Mycoplasma genitalium was used as a reference to identify the presence of iga nucleotide sequence in U. urealyticum. Convincing evidence were obtained after PCR amplification of ureaplasma DNA using primers designed to be compatible with putative iga gene of M. genitalium followed by the discovery of 100% sequence homology of amplified ureaplasma iga gene and iga gene of M. genitalium mentioned in establish data. IgA1 protease activity of U. urealytium has been detectable in the cell rather than in media culture, suggesting that IgA1 protease is not secreted out of cell. It was proofed that IgA1 protease is membrane bound enzyme capable of digesting IgA1 in mucosal tissues of various organs and considered as potential virulence factor for ureaplasma that cause disease or gain entry to mucosal membrane. The existence of IgA1 protease activity in bacterial plasma membrane would have implication in ureaplasma management such as diagnosis and therapy of ureaplasma infection. (Med J Indones 2005;14: 204-14)

Published
2005-11-01
How to Cite
1.
Soeharso P. Development of bioassay for pathogenecity testing of Ureaplasma urealyticum as part of host-pathogen communication. Med J Indones [Internet]. 2005Nov.1 [cited 2020Dec.3];14(4):204-14. Available from: http://mji.ui.ac.id/journal/index.php/mji/article/view/197
Section
Basic Medical Research

Most read articles by the same author(s)